Literature DB >> 25392483

Baths salts, spice, and related designer drugs: the science behind the headlines.

Michael H Baumann1, Ernesto Solis2, Lucas R Watterson3, Julie A Marusich4, William E Fantegrossi5, Jenny L Wiley4.   

Abstract

The abuse of synthetic psychoactive substances known as "designer drugs," or "new psychoactive substances" (NPS), is increasing at an alarming rate. NPS are purchased as alternatives to traditional illicit drugs of abuse and are manufactured to circumvent laws regulating the sale and use of controlled substances. Synthetic cathinones (i.e., "bath salts") and synthetic cannabinoids (i.e., "spice") are two types of NPS that have received substantial media attention. Although low recreational doses of bath salts or spice compounds can produce desirable effects, high doses or chronic exposure often leads to dangerous medical consequences, including psychosis, violent behaviors, tachycardia, hyperthermia, and even death. Despite the popularity of NPS, there is a paucity of scientific data about these drugs. Here we provide a brief up-to-date review describing the mechanisms of action and neurobiological effects of synthetic cathinones and cannabinoids.
Copyright © 2014 the authors 0270-6474/14/3415150-09$15.00/0.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25392483      PMCID: PMC4228124          DOI: 10.1523/JNEUROSCI.3223-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  143 in total

Review 1.  Endocannabinoids in pain modulation.

Authors:  J M Walker; S M Huang
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Feb-Mar       Impact factor: 4.006

2.  Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.

Authors: 
Journal:  Fed Regist       Date:  2011-10-21

Review 3.  Current "legal highs".

Authors:  Lucas A Johnson; Rebecca L Johnson; Ray-Bernard Portier
Journal:  J Emerg Med       Date:  2013-03-23       Impact factor: 1.484

4.  Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model.

Authors:  Timothy W Lefever; Julie A Marusich; Kateland R Antonazzo; Jenny L Wiley
Journal:  Pharmacol Biochem Behav       Date:  2014-01-09       Impact factor: 3.533

5.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

6.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Megan Grabenauer; Brian F Thomas; Julie A Marusich; Scott Wegner; M Foster Olive
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

7.  UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products.

Authors:  Pierce Kavanagh; Andrej Grigoryev; Sergey Savchuk; Irina Mikhura; Andrew Formanovsky
Journal:  Drug Test Anal       Date:  2013-01-11       Impact factor: 3.345

8.  1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.

Authors:  Peter C Meltzer; David Butler; Jeffrey R Deschamps; Bertha K Madras
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

9.  The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts"

Authors:  Lucas R Watterson; Lauren Hood; Kaveish Sewalia; Seven E Tomek; Stephanie Yahn; Craig Trevor Johnson; Scott Wegner; Bruce E Blough; Julie A Marusich; M Foster Olive
Journal:  J Addict Res Ther       Date:  2012-12-01

10.  Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.

Authors:  L D Simmler; A Rickli; M C Hoener; M E Liechti
Journal:  Neuropharmacology       Date:  2013-11-22       Impact factor: 5.250

View more
  42 in total

1.  Abuse of New Psychoactive Substances: Threats and Solutions.

Authors:  Michael H Baumann; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2015-08-25       Impact factor: 7.853

Review 2.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

3.  Emerging threats in addiction: will novel psychoactive substances contribute to exacerbating the ongoing drug overdose epidemic?

Authors:  F Scott Hall; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2019-03       Impact factor: 4.530

Review 4.  Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Authors:  Michael H Baumann; Mohammad O Bukhari; Kurt R Lehner; Sebastien Anizan; Kenner C Rice; Marta Concheiro; Marilyn A Huestis
Journal:  Curr Top Behav Neurosci       Date:  2017

5.  Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.

Authors:  J A Suyama; M L Banks; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2018-09-19       Impact factor: 4.530

6.  Analysis of neurotransmitter levels in addiction-related brain regions during synthetic cathinone self-administration in male Sprague-Dawley rats.

Authors:  Julie A Marusich; Elaine A Gay; Bruce E Blough
Journal:  Psychopharmacology (Berl)       Date:  2018-09-06       Impact factor: 4.530

7.  Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.

Authors:  Julie A Marusich; Jenny L Wiley; Timothy W Lefever; Purvi R Patel; Brian F Thomas
Journal:  Neuropharmacology       Date:  2017-11-04       Impact factor: 5.250

8.  Problem-solving deficits in methcathinone use disorder.

Authors:  Hang-Bin Zhang; Di Zhao; Yu-Ping Liu; Li-Xun Wang; Bo Yang; Ti-Fei Yuan
Journal:  Psychopharmacology (Berl)       Date:  2021-07-22       Impact factor: 4.530

9.  Effects of 3,4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerability.

Authors:  Claudia J Woloshchuk; Katharine H Nelson; Kenner C Rice; Anthony L Riley
Journal:  Drug Alcohol Depend       Date:  2016-08-07       Impact factor: 4.492

Review 10.  Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.

Authors:  Dennis J Sholler; Marilyn A Huestis; Benjamin Amendolara; Ryan Vandrey; Ziva D Cooper
Journal:  Pharmacol Biochem Behav       Date:  2020-10-18       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.